COVID-19: immunopathology and its implications for therapy

This article gives a good overview of data indicating how COVID-19 acts on the body, specifically in activating the immune system. The authors emphasize the need for standardized treatment protocol while also considering that a combination of treatments may be the most effective. Additionally, they emphasize how much is still unknown about how long and … Read more

Scientists Identify 69 Drugs to Test Against Coronavirus (New York Times) and Source Paper

This is an article from the New York Times that shares the results of a study done at UCSF to find possible cellular targets for COVID-19 as well as drugs that are already approved on in clinical trials that could help. Carl Zimmer does a good job of accurately presenting the work from the paper … Read more

Images of COVID-19 Infecting a Healthy Cell

Researchers at the Oswaldo Cruz Foundation in Brazil are studying the replication of the virus and while using a transmission electron microscope, were able to image the exact moment when the virus infects and invades a healthy cells. The link below leads to an article with three of the images captured during this discovery. https://www.telegraph.co.uk/global-health/science-and-disease/moment-coronavirus-infects-healthy-cell-captured-pictures/

51 Recovered Coronavirus Patients Test Positive Again in South Korea

There’s been a lot of discussion and speculation as to whether or not someone who has already contracted Coronavirus can get sick again. I came across this article today, which presents somewhat pessimistic findings… https://nypost.com/2020/04/07/51-recovered-coronavirus-patients-test-positive-again-in-south-korea/ Brown, Lee. “51 Recovered Coronavirus Patients Test Positive Again in South Korea.” The New York Post. April 7, 2020.

Freeman, “Inovio Pharmaceuticals begins human trials for COVID-19 vaccine”

Article link: https://www.sandiegouniontribune.com/business/biotech/story/2020-04-06/inovio-pharmaceuticals-begins-phase-1-human-trials-for-covid-19-vaccine Author: Mike FreemanPublished on April 6, 2020, San Diego Union-Tribune Developed by Inovio Pharmaceuticals, a novel plasmid DNA-based vaccine to prevent COVID-19 has started its first phase of clinical testing with humans. Unlike traditional vaccines, this one will artificially incorporate the DNA of antibodies that destroy the virus into the patient’s own … Read more

Potential Vaccine for SARS-COV-2

Today, The Lancet published an article from researchers at the University of Pittsburgh Medical Center about a new potential vaccine for COVID-19. The vaccine generates a potent, antigen-specific antibody response to the virus. The vaccine has been effective in mouse trials thus far. Further, the researchers were successful in designing an effective method of administration … Read more

COVID-19 Is Here. Now How Long Will It Last?

Interview with Yale Epidemiologist and specialist in microbial diseases suggesting that 50-60% of people who are infected don’t exhibit symptoms at all – really puts things in perspective — and, means that many of us have probably already gotten the virus or are carrying it right now. This interview really speaks to the sheer amount … Read more

Cheng et al., “Organ‐protective Effect of Angiotensin‐converting Enzyme 2 and its Effect on the Prognosis of COVID‐19”

Article link: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25785 Published in the Journal of Medical Virology on March 27, 2020, Cheng and colleagues demonstrate that an enzyme found in the lungs, Angiotensin-converting Enzyme 2 (ACE2), is highly protective against acute lung injury – particularly in the case of COVID-19 patients who are in critical condition. Therefore, the authors believe that the … Read more